Aflatoxin B1-induced DNA adduct formation in murine kidney and liver

Pawel Jaruga1, Vladimir L Vartanian2, Irina G Minko2

  • 1Biomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, USA.

Insights

Aflatoxin B1 DNA adducts form in kidneys, but at lower levels than in the liver. This study challenges the idea that reactive oxygen species drive acute aflatoxin-induced kidney damage.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Biochemistry

Background:

  • Aflatoxicosis, caused by aflatoxin ingestion, is a severe condition affecting the kidneys and liver.
  • Chronic exposure to aflatoxins is associated with an increased risk of liver cancer.
  • The exact mechanisms of aflatoxin-induced nephrotoxicity are not fully understood.

Purpose of the Study:

  • To investigate the formation of aflatoxin B1 (AFB1) DNA adducts in kidney tissue.
  • To compare AFB1 adduct levels in the kidney and liver.
  • To evaluate the role of reactive oxygen species in AFB1-induced nephrotoxicity.

Main Methods:

  • Utilized advanced mass spectrometry techniques to detect AFB1 DNA adducts.
  • Quantified AFB1 adducts in both kidney and liver tissues from exposed animals.
  • Measured oxidatively-induced DNA base damage to assess reactive oxygen species involvement.

Main Results:

  • AFB1 DNA adducts were detected in kidney tissue, though approximately 100-fold lower than in the liver.
  • Tissue-specific differences in cytochrome P450 expression likely influence AFB1 activation.
  • No evidence of genotoxic DNA base damage from reactive oxygen species was found, challenging existing hypotheses.

Conclusions:

  • AFB1 does form DNA adducts in the kidney, indicating direct interaction.
  • The lower adduct levels in the kidney suggest differential metabolic activation compared to the liver.
  • The findings do not support reactive oxygen species as the primary mechanism for acute aflatoxin-induced nephrotoxicity.